Literature DB >> 22329490

Mucopolysaccharidosis type VI in a Miniature Poodle-type dog caused by a deletion in the arylsulphatase B gene.

R D Jolly1, J J Hopwood, N R Marshall, K S Jenkins, D J Thompson, K E Dittmer, J C Thompson, A O Fedele, K Raj, U Giger.   

Abstract

AIM: To investigate and characterise an inborn error of metabolism in a dog with skeletal and ocular abnormalities.
METHODS: A 2.5-year-old small male Miniature Poodle-like dog was presented with gross joint laxity and bilateral corneal opacities. Clinical examination was augmented by routine haematology, serum chemistry, radiographs, pathology, enzymology and molecular genetic studies. Euthanasia was requested when the dog was 3 years of age because of progressively decreasing quality of life.
RESULTS: Radiology revealed generalised epiphyseal dysplasia, malformed vertebral bodies, luxation/subluxation of appendicular and lumbosacral joints with hypoplasia of the odontoid process and hyoid apparatus. These clinical and radiographic findings, together with a positive urinary Berry spot test for mucopolysaccharides, and metachromatic granules in leucocytes, were indicative of a mucopolysaccharidosis (MPS), a lysosomal storage disease. Histological lesions included vacuolation of stromal cells of the cornea, fibroblasts, chondrocytes, macrophages and renal cells. The brain was essentially normal except for moderate secondary Wallerian-type degeneration in motor and sensory tracts of the hind brain. Dermatan sulphate-uria was present and enzymology revealed negligible activity of N-acetylgalactosamine-4-sulphatase, also known as arylsulphatase B, in cultured fibroblasts and liver tissue. A novel homozygous 22 base pair (bp) deletion in exon 1 of this enzyme's gene was identified (c.103_124del), which caused aframe-shift and subsequent premature stop codon. The "Wisdom pure breed-mixed breed" test reported the dog as a cross between a Miniature and Toy Poodle.
CONCLUSIONS: The clinicopathological features are similar to those of MPS type VI as previously described in dogs, cats and other species, and this clinical diagnosis was confirmed by enzymology and molecular genetic studies. This is an autosomal recessively inherited lysosomal storage disease. CLINICAL RELEVANCE: The prevalence of MPS VI in Miniature or Toy Poodles in New Zealand and elsewhere is currently unknown. Due to the congenital nature of the disorder, malformed pups may be subject to euthanasia without investigation and the potential genetic problem in the breed may not be fully recognised. The establishment of a molecular genetic test now permits screening for this mutation as a basis to an informed breeding policy.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22329490      PMCID: PMC3401909          DOI: 10.1080/00480169.2011.642791

Source DB:  PubMed          Journal:  N Z Vet J        ISSN: 0048-0169            Impact factor:   1.628


  17 in total

1.  Clinical vignette. Mucopolysaccharidosis VI in a miniature pinscher.

Authors:  T M Neer; S M Dial; R Pechman; P Wang; J L Oliver; U Giger
Journal:  J Vet Intern Med       Date:  1995 Nov-Dec       Impact factor: 3.333

2.  High-resolution electrophoresis of urinary glycosaminoglycans: an improved screening test for the mucopolysaccharidoses.

Authors:  J J Hopwood; J R Harrison
Journal:  Anal Biochem       Date:  1982-01-01       Impact factor: 3.365

3.  Morphologic and biochemical studies of canine mucopolysaccharidosis I.

Authors:  R M Shull; R G Helman; E Spellacy; G Constantopoulos; R J Munger; E F Neufeld
Journal:  Am J Pathol       Date:  1984-03       Impact factor: 4.307

4.  Beta-glucuronidase deficiency in a dog: a model of human mucopolysaccharidosis VII.

Authors:  M E Haskins; R J Desnick; N DiFerrante; P F Jezyk; D F Patterson
Journal:  Pediatr Res       Date:  1984-10       Impact factor: 3.756

5.  Prevalence of mucopolysaccharidosis type VI mutations in Siamese cats.

Authors:  A C Crawley; F H Muntz; M E Haskins; B R Jones; J J Hopwood
Journal:  J Vet Intern Med       Date:  2003 Jul-Aug       Impact factor: 3.333

6.  Diagnosis of Sanfilippo type A syndrome by estimation of sulfamidase activity using a radiolabelled tetrasaccharide substrate.

Authors:  J J Hopwood; H Elliott
Journal:  Clin Chim Acta       Date:  1982-08-18       Impact factor: 3.786

7.  MPS screening methods, the Berry spot and acid turbidity tests, cause a high incidence of false-negative results in sanfilippo and morquio syndromes.

Authors:  Chang Chih-Kuang; Lin Shuan-Pei; Lee Shyue-Jye; Wang Tuen-Jen
Journal:  J Clin Lab Anal       Date:  2002       Impact factor: 2.352

8.  Genetic structure of the purebred domestic dog.

Authors:  Heidi G Parker; Lisa V Kim; Nathan B Sutter; Scott Carlson; Travis D Lorentzen; Tiffany B Malek; Gary S Johnson; Hawkins B DeFrance; Elaine A Ostrander; Leonid Kruglyak
Journal:  Science       Date:  2004-05-21       Impact factor: 47.728

9.  Immune tolerance improves the efficacy of enzyme replacement therapy in canine mucopolysaccharidosis I.

Authors:  Patricia Dickson; Maryn Peinovich; Michael McEntee; Thomas Lester; Steven Le; Aimee Krieger; Hayden Manuel; Catherine Jabagat; Merry Passage; Emil D Kakkis
Journal:  J Clin Invest       Date:  2008-08       Impact factor: 14.808

10.  Mucopolysaccharidosis type VII in a German Shepherd Dog.

Authors:  Deborah C Silverstein Dombrowski; K Paige Carmichael; Ping Wang; Thomas M O'Malley; Mark E Haskins; Urs Giger
Journal:  J Am Vet Med Assoc       Date:  2004-02-15       Impact factor: 1.936

View more
  9 in total

1.  Mucopolysaccharidosis type VI in a juvenile miniature schnauzer dog with concurrent hypertriglyceridemia, necrotizing pancreatitis, and diabetic ketoacidosis.

Authors:  Mayrim L Pérez; Heather A Kridel; Alex Gallagher; Barbara J Sheppard; Shona Reese; Hirotaka Kondo; Rick Alleman; Urs Giger
Journal:  Can Vet J       Date:  2015-03       Impact factor: 1.008

2.  ARSB gene variants causing Mucopolysaccharidosis VI in Miniature Pinscher and Miniature Schnauzer dogs.

Authors:  K Raj; L Berman-Booty; P Foureman; U Giger
Journal:  Anim Genet       Date:  2020-09-28       Impact factor: 3.169

3.  Dried blood spots for the enzymatic diagnosis of lysosomal storage diseases in dogs and cats.

Authors:  Adrian C Sewell; Mark E Haskins; Urs Giger
Journal:  Vet Clin Pathol       Date:  2012-11-02       Impact factor: 1.180

4.  Mucopolysaccharidosis Type VI in a Great Dane Caused by a Nonsense Mutation in the ARSB Gene.

Authors:  Ping Wang; Carol Margolis; Gloria Lin; Elizabeth L Buza; Scott Quick; Karthik Raj; Rachel Han; Urs Giger
Journal:  Vet Pathol       Date:  2017-11-20       Impact factor: 2.221

Review 5.  Canine and Feline Models of Human Genetic Diseases and Their Contributions to Advancing Clinical Therapies
.

Authors:  Brittney L Gurda; Allison M Bradbury; Charles H Vite
Journal:  Yale J Biol Med       Date:  2017-09-25

6.  Whole genome sequencing for mutation discovery in a single case of lysosomal storage disease (MPS type 1) in the dog.

Authors:  Tamer A Mansour; Kevin D Woolard; Karen L Vernau; Devin M Ancona; Sara M Thomasy; Lionel Sebbag; Bret A Moore; Marguerite F Knipe; Haitham A Seada; Tina M Cowan; Miriam Aguilar; C Titus Brown; Danika L Bannasch
Journal:  Sci Rep       Date:  2020-04-16       Impact factor: 4.379

Review 7.  DNA testing in neurologic diseases.

Authors:  D P O'Brien; T Leeb
Journal:  J Vet Intern Med       Date:  2014-06-24       Impact factor: 3.333

8.  Two mixed breed dogs with sensory neuropathy are homozygous for an inversion disrupting FAM134B previously identified in Border Collies.

Authors:  Pablo Amengual-Batle; Clare Rusbridge; Roberto José-López; Lorenzo Golini; G Diane Shelton; Cathryn S Mellersh; Rodrigo Gutierrez-Quintana
Journal:  J Vet Intern Med       Date:  2018-10-11       Impact factor: 3.333

Review 9.  Mucopolysaccharidosis Type VI, an Updated Overview of the Disease.

Authors:  Francesca D'Avanzo; Alessandra Zanetti; Concetta De Filippis; Rosella Tomanin
Journal:  Int J Mol Sci       Date:  2021-12-15       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.